NCT04440566View on ClinicalTrials.gov

O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

February 14, 2022

Study Completion Date

February 14, 2022

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

blood sample

30 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation

Trial Locations (1)

Unknown

CHU de Bordeaux - Service d'Immunologie et Immunogénétique, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04440566 - O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter